University Hospitals Of North Midlands NHS Trust

Management of oesophago-gastric cancer

Time period: 2021-2023
Organisation National
Number of oesophago-gastric (OG) cancer patients in audit 351 19,512
Diagnosis
– Patients diagnosed after an emergency admission**
** Percent figure accounts for differences in mix of patients across organisations
21% 21.0%
– % diagnosed with stage 4 disease
(denominator: all people diagnosed)
41% 37.0%
– % with unknown stage
(denominator: all people diagnosed)
10% 17.0%
Waiting times
– % diagnosed within 28 days of referral
(denominator: people diagnosed after urgent GP referral)
60% 73.0%
– % treated within 62 days of referral
(denominator: people receiving disease-targeted treatment after urgent GP referral)
13% 26.0%
Supportive care
– % seen by a clinical nurse specialist (CNS) at diagnosis
(denominator: people with complete CNS data)
97% 93.0%
– % seen by a clinical nurse specialist (CNS) at diagnosis
(denominator: all people diagnosed)
82% 60.0%
– % with complete CNS data 85% 65.0%

N/A: results not presented due to a denominator of <10; for the CNS indicators, results are not presented if the denominator is <10 or if data completeness of the CNS variable is poor (<50%)

Survival after oesophago-gastric cancer surgery

Time period: 2020-2023
Organisation National
90-day postoperative survival (risk-adjusted) 94.5% 96.4%
1-year postoperative survival (risk-adjusted) 77.0% 83.0%

Compare trust outcomes

Download this data as a PDF